Skip to main content
. 2015 Jan 23;17(1):134–140. doi: 10.1016/j.neo.2014.12.001

Table 4.

Comparative Survival Analyses of GIST Patients With and Without Secondary Malignancies

(Ntotal= 267/569) With 2nd NPL
Without 2nd NPL
Univariate Cox model
Multivariate Cox model
% (N) % (N) P, HR (95% CI) P, HR (95% CI)
Disease-specific-survival
 1-year DSS 99.0 (194) 96.6 (435) P = .603, HR 1.164 (0.657;2.061) P = .880, HR 1.053 (0.536;2.070)
 3-year DSS 96.5 (135) 93.4 (319)
 5-year DSS 90.8 (88) 90.9 (212)
Overall-survival
 1-year OS 88.5 (194) 94.0 (435) P < .001 HR 0.397 (0.298;0.530) P < .001 HR 0.402 (0.282;0.575)
 3-year OS 75.0 (135) 88.3 (319)
 5-year OS 62.8 (88) 83.4 (212)
Disease-free survival
 1-year DFS 90.7 (159) 88.1 (367) P = .586 HR 1.118 (0.748;1.672) P = .616 HR 0.883 (0.544;1.435)
 3-year DFS 88.1 (108) 83.4 (258)
 5-year DFS 82.7 (66) 81.5 (173)

DSS, disease specific survival; DSF, disease free survival; OS, overall survival; HR, hazard ratio.

Multivariate Cox proportional hazards regression model has been adjusted considering the variables age, gender, mitotic rate, tumor size and localization (GIST).